{{ 'fb_in_app_browser_popup.desc' | translate }} {{ 'fb_in_app_browser_popup.copy_link' | translate }}
{{ 'in_app_browser_popup.desc' | translate }}
您好!訂單金額滿 NTD $2,500 立享『免運』優惠!
{{ childProduct.title_translations | translateModel }}
{{ getChildVariationShorthand(childProduct.child_variation) }}
{{ getSelectedItemDetail(selectedChildProduct, item).childProductName }} x {{ selectedChildProduct.quantity || 1 }}
{{ getSelectedItemDetail(selectedChildProduct, item).childVariationName }}
蝦紅素(Astaxanthin)是一種存在於紅藻海洋生物中的一種類胡蘿蔔素,主要提升抗氧化和抗炎能力。
近年來在眼部保健領域引起了廣泛關注,蝦紅素對眼睛健康具有多方面的益處:
本文將深入探討蝦紅素對眼部健康的多重益處,並引用相關研究以支持這些觀點。
在探討紅藻萃取物的蝦紅素(Astaxanthin)對眼部保健的益處時,將其與葉黃素油(Lutein Oil)和小米草萃取物(Eyebright Extract)結合使用,可能提供更全面的眼部保護。
長時間使用電腦和手機等電子設備,容易導致眼睛疲勞和乾澀。蝦紅素可減輕這些症狀,提升視覺舒適度(Nakamura et al., 2004)。
夜間駕駛需要良好的視覺敏銳度。蝦紅素可維持夜間視力,縮短暗適應時間,提升夜間駕駛的安全性(Nagaki et al., 2005)。
結合蝦紅素、葉黃素和歐洲越橘萃取物,可能提供更全面的眼部保護。蝦紅素作為一種天然物質,具有多種潛在的視覺維持益處,特別是在增強微血管循環、保護黃斑部、減少視網膜氧化壓力,以及預防白內障和黃斑部病變等方面。
明亮補給品 6000
包裝規格:60 粒 / 瓶,30 粒 / 包
食用方法:一 次 1 粒、一 天 1 - 3 次
加入恆宇生醫 官方會員,享優惠!
Abascal, K., & Yarnell, E. (2002). The medicinal uses of Euphrasia (Eyebright). Alternative and Complementary Therapies, 8(3), 128-134.
Guerin, M., Huntley, M. E., & Olaizola, M. (2003). Haematococcus astaxanthin: applications for human health and nutrition. Trends in Biotechnology, 21(5), 210-216.
Kidd, P. (2011). Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Alternative Medicine Review, 16(4), 355-364.
Krinsky, N. I., Landrum, J. T., & Bone, R. A. (2003). Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annual Review of Nutrition, 23, 171-201.
Nagaki, Y., Mihara, M., Takahashi, J., Kitamura, A., Horita, Y., Sugiura, Y., & Tsukahara, H. (2005). The effect of astaxanthin on retinal capillary blood flow in normal volunteers. Journal of Clinical Therapeutics and Medicines, 21(5), 537-542.
Nakamura, A., et al. (2004). Effects of astaxanthin on accommodative function and asthenopia—efficacy identification study in healthy volunteers. Journal of Clinical Therapeutics & Medicines, 20(1), 41-54.
Nishikawa, Y., Minamiyama, Y., Yamamoto, M., Takemura, S., & Okada, S. (2005). Astaxanthin protects β-cells against glucose toxicity in diabetic db/db mice. Redox Report, 10(5), 294-300.
Paduch, R., Kandefer-Szerszeń, M., Trytek, M., & Fiedurek, J. (2014). Terpenes: substances useful in human healthcare. Archivum Immunologiae et Therapiae Experimentalis, 62, 141-152.
Richer, S., Stiles, W., Statkute, L., Pulido, J., Frankowski, J., Rudy, D., Pei, K., Tsipursky, M., & Nyland, J. (2004). Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry-Journal of the American Optometric Association, 75(4), 216-230.
Suzuki, Y., Ohgami, K., Shiratori, K., Jin, X. H., Ilieva, I., Koyama, Y., ... & Ohno, S. (2006). Suppressive effects of astaxanthin against rat endotoxin-induced uveitis by inhibiting the NF-κB signaling pathway. Experimental eye research, 82(2), 275-281.
Stringham, J. M., & Hammond, B. R. (2005). Dietary lutein and zeaxanthin: possible effects on visual function. Nutrition Reviews, 63(2), 59-64.